Barbara Lettiero

807 total citations
16 papers, 653 citations indexed

About

Barbara Lettiero is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Barbara Lettiero has authored 16 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Physiology. Recurrent topics in Barbara Lettiero's work include Cancer, Lipids, and Metabolism (4 papers), Alzheimer's disease research and treatments (3 papers) and Lipid Membrane Structure and Behavior (3 papers). Barbara Lettiero is often cited by papers focused on Cancer, Lipids, and Metabolism (4 papers), Alzheimer's disease research and treatments (3 papers) and Lipid Membrane Structure and Behavior (3 papers). Barbara Lettiero collaborates with scholars based in Sweden, Denmark and Italy. Barbara Lettiero's co-authors include S. Moein Moghimi, Signe Borgquist, Sayed Hossein Hashemi, Siker Kimbung, Alina J. Andersen, A. Christy Hunter, Davoud Ahmadvand, Ilaria Rivolta, Alice Panariti and Thomas L. Andresen and has published in prestigious journals such as ACS Nano, Biomaterials and Scientific Reports.

In The Last Decade

Barbara Lettiero

16 papers receiving 649 citations

Peers

Countries citing papers authored by Barbara Lettiero

Since Specialization

Citations

This map shows the geographic impact of Barbara Lettiero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Lettiero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Lettiero more than expected).

Fields of papers citing papers by Barbara Lettiero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Lettiero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Lettiero. The network helps show where Barbara Lettiero may publish in the future.

Co-authorship network of co-authors of Barbara Lettiero

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Lettiero. A scholar is included among the top collaborators of Barbara Lettiero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Lettiero. Barbara Lettiero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer 2023 ·BMC Research Notes ·Malin Dahlgren, Barbara Lettiero, (unknown), (unknown), Alexander Gaber, Björn Nodin, Sofia K. Gruvberger-Saal, Lao H. Saal, Jillian Howlin	2
2	The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial 2020 ·Cancer & Metabolism ·(unknown), Julien A. Menard, Ann H. Rosendahl, Barbara Lettiero, Pär‐Ola Bendahl, Mattias Belting, Signe Borgquist	15
3	Adipocytes and Obesity-Related Conditions Jointly Promote Breast Cancer Cell Growth and Motility: Associations With CAP1 for Prognosis 2018 ·Frontiers in Endocrinology ·Ann H. Rosendahl, (unknown), Barbara Lettiero, Siker Kimbung, Signe Borgquist	20
4	Insensitivity to atorvastatin is associated with increased accumulation of intracellular lipid droplets and fatty acid metabolism in breast cancer cells 2018 ·Scientific Reports ·Barbara Lettiero, (unknown), Siker Kimbung, Signe Borgquist	27
5	[Molecular characterization of hereditary colorectal cancer in Peru]. 2016 ·PubMed ·(unknown), (unknown), Barbara Lettiero, Patrik Wernhoff, Mev Dominguez–Valentin	2
6	ImmunoPEGliposome-mediated reduction of blood and brain amyloid levels in a mouse model of Alzheimer's disease is restricted to aged animals 2016 ·Biomaterials ·Lara Ordóñez‐Gutiérrez, (unknown), Davoud Ahmadvand, Barbara Lettiero, Linping Wu, Marta Antón, Orfeu Flores, S. Moein Moghimi, Francisco Wandosell	32
7	High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer 2016 ·Oncotarget ·Siker Kimbung, Barbara Lettiero, (unknown), Ana Bosch, Signe Borgquist	65
8	Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours 2015 ·PeerJ ·Jillian Howlin, Helena Cirenajwis, Barbara Lettiero, Johan Staaf, Martin Lauss, Lao H. Saal, Åke Borg, Sofia K. Gruvberger-Saal, Göran Jönsson	16
9	Dynamic Investigation of Interaction of Biocompatible Iron Oxide Nanoparticles with Epithelial Cells for Biomedical Applications 2013 ·Journal of Biomedical Nanotechnology ·Alice Panariti, Barbara Lettiero, R. Alexandrescu, Maddalena Collini, Laura Sironi, Munish Chanana, I. Morjan, Dayang Wang, Giuseppe Chirico, Giuseppe Miserocchi, Cecilia Bucci, Ilaria Rivolta	9
10	PEGylated Nanoparticles Bind to and Alter Amyloid-Beta Peptide Conformation: Toward Engineering of Functional Nanomedicines for Alzheimer’s Disease 2012 ·ACS Nano ·Davide Brambilla, Romain Verpillot, Benjamin Le Droumaguet, Julien Nicolas, Myriam Taverna, Juraj Kóňa, Barbara Lettiero, Sayed Hossein Hashemi, Line De Kimpe, Mara Canovi, Marco Gobbi, Valérie Nicolas, Wiep Scheper, S. Moein Moghimi, Igor Tvaroška, Patrick Couvreur, Karine Andrieux	158
11	Complement system and the brain: Selected pathologies and avenues toward engineering of neurological nanomedicines 2011 ·Journal of Controlled Release ·Barbara Lettiero, Alina J. Andersen, A. Christy Hunter, S. Moein Moghimi	22
12	Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles. 2011 ·PubMed ·Ilaria Rivolta, Alice Panariti, Barbara Lettiero, Silvia Sesana, Paolo Gasco, Maria Rosa Gasco, Massimo Masserini, G. Miserocchi	113
13	A biophysical model of intracellular distribution and perinuclear accumulation of particulate matter 2011 ·Biophysical Chemistry ·Ilaria Rivolta, Alice Panariti, Maddalena Collini, Barbara Lettiero, Laura D’Alfonso, Laura Sironi, Giuseppe Miserocchi, Giuseppe Chirico	9
14	Complement activation cascade triggered by PEG–PL engineered nanomedicines and carbon nanotubes: The challenges ahead 2010 ·Journal of Controlled Release ·S. Moein Moghimi, Alina J. Andersen, Sayed Hossein Hashemi, Barbara Lettiero, Davoud Ahmadvand, A. Christy Hunter, Thomas L. Andresen, Islam Hamad, János Szebeni	137
15	SLN As Vehicle For A Model Drug: A Biophysical Study 2010 ·AIP conference proceedings ·Alice Panariti, Ilaria Rivolta, Barbara Lettiero, Giuseppe Chirico, Paolo Gasco, G. Miserocchi, E. Borsella	1
16	Hypoxia‐induced modifications in plasma membranes and lipid microdomains in A549 cells and primary human alveolar cells 2008 ·Journal of Cellular Biochemistry ·Laura Botto, Egidio Beretta, Alessandra Bulbarelli, Ilaria Rivolta, Barbara Lettiero, Biagio Eugenio Leone, Giuseppe Miserocchi, Paola Palestini	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact